| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 2,215 | 2,415 | 2,508 | 2,522 | 2,582 | 2,850 | 2,922 | 3,125 | 2,179 | 2,808 | 2,781 | 2,931 | 4,079 | 3,725 | 3,662 | 3,580 | 3,812 | 4,274 | 4,299 | 4,322 | 4,452 | 4,873 | 4,880 | 4,981 | 5,134 | 5,633 | 5,596 | 5,664 | 5,896 | 6,365 |
| Expenses | 1,981 | 2,141 | 2,222 | 2,220 | 2,218 | 2,427 | 2,482 | 2,542 | 2,159 | 2,470 | 2,370 | 2,456 | 3,245 | 3,102 | 3,052 | 3,083 | 3,317 | 3,699 | 3,780 | 3,814 | 3,909 | 4,219 | 4,237 | 4,303 | 4,411 | 4,774 | 4,765 | 4,823 | 4,990 | 5,362 |
| EBITDA | 234 | 274 | 286 | 302 | 364 | 423 | 440 | 583 | 21 | 337 | 411 | 475 | 835 | 623 | 610 | 497 | 495 | 575 | 519 | 508 | 543 | 654 | 643 | 677 | 724 | 859 | 831 | 841 | 906 | 1,002 |
| Operating Profit % | 10 % | 11 % | 11 % | 11 % | 14 % | 15 % | 15 % | 13 % | 1 % | 11 % | 14 % | 14 % | 14 % | 17 % | 16 % | 13 % | 13 % | 13 % | 11 % | 11 % | 12 % | 13 % | 13 % | 13 % | 13 % | 15 % | 14 % | 14 % | 15 % | 15 % |
| Depreciation | 95 | 97 | 98 | 105 | 144 | 155 | 157 | 164 | 160 | 149 | 125 | 139 | 141 | 145 | 149 | 166 | 148 | 155 | 153 | 159 | 167 | 163 | 167 | 190 | 177 | 185 | 185 | 211 | 215 | 218 |
| Interest | 76 | 81 | 84 | 85 | 126 | 134 | 137 | 135 | 127 | 122 | 101 | 99 | 95 | 95 | 94 | 95 | 93 | 93 | 100 | 95 | 106 | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 |
| Profit Before Tax | 63 | 96 | 103 | 112 | 94 | 134 | 145 | 284 | -267 | 66 | 185 | 238 | 599 | 383 | 368 | 236 | 254 | 327 | 266 | 254 | 270 | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 | 675 |
| Tax | 39 | 42 | 53 | 39 | 45 | 51 | 55 | 74 | -41 | 7 | 51 | 68 | 99 | 116 | 124 | 139 | -70 | 114 | 104 | 108 | 97 | 130 | 109 | 110 | 115 | 162 | 157 | 101 | 142 | 181 |
| Net Profit | 23 | 54 | 50 | 73 | 49 | 83 | 90 | 210 | -226 | 59 | 134 | 170 | 501 | 267 | 243 | 97 | 324 | 213 | 162 | 146 | 173 | 249 | 254 | 258 | 316 | 396 | 379 | 415 | 441 | 494 |
| EPS in ₹ | 2.44 | 4.56 | 4.10 | 6.10 | 4.11 | 6.20 | 6.62 | 15.77 | -14.96 | 4.33 | 9.38 | 11.77 | 34.03 | 17.24 | 15.88 | 6.27 | 22.05 | 14.19 | 10.67 | 10.05 | 11.59 | 16.20 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 27.10 | 30.10 | 33.19 |
Apollo Hospitals
Apollo Hospitals
6,793.50
-9.50
(-0.14%)
Market Cap
97,680.11 Cr
PE Ratio
56.56
Volume
5,15,312.00
Day High - Low
6,842.00 - 6,708.50
52W High-Low
8,099.50 - 6,001.00
Key Fundamentals
Market Cap
97,680.11 Cr
EPS
100.56
PE Ratio
56.56
PB Ratio
10.76
Book Value
631.88
EBITDA
3,222.10
Dividend Yield
0.19 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
17.39
Debt to Equity
0.61
Analyst Rating and Forecast
- By Refinitiv from26 analysts
Actual
Company News
View All News
CRISIL reaffirms Apollo Hospitals' AA+ rating with positive outlook revision for Rs. 2800 crores bank facilities and Rs. 19 crores debentures, citing strong market position and improving financials.
Schroder Investment Management sold 206,610 shares of Apollo Hospitals Enterprise Ltd on 21 January 2026, reducing their stake from 3.14% to 2.99% through open market transactions.
Apollo Hospitals Enterprise receives regulatory permission to acquire an additional 30.58% stake in its subsidiary Apollo Health And Lifestyle, strengthening its position in the wellness segment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
6,793.50 | #1 97,680.11 | #5 56.56 | #1 21,994.30 | #7 14.76 | #1 1,505 | #5 24.84 | 32.67 | |
975.50 | 94,893.65 | 71.08 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 32.96 | |
838.45 | 63,299.47 | 61.31 | 7,849.70 | 13.25 | 809 | 70.27 | 34.12 | |
1,725.90 | 35,270.63 | #1 42.28 | 5,575.00 | 12.29 | 790 | 30.03 | 33.46 | |
554.20 | 28,714.27 | 78.88 | 4,286.70 | 15.12 | 337 | 14.65 | 32.68 | |
1,042.90 | 28,032.15 | 49.30 | 3,771.40 | 12.59 | 481 | 21.10 | 28.73 | |
615.00 | 24,608.54 | 65.49 | 3,067.00 | 21.98 | 415 | -40.35 | 32.23 | |
445.95 | 14,112.98 | 99.68 | 1,757.00 | 27.64 | 110 | 71.36 | 25.74 | |
1,188.50 | 12,070.31 | 47.25 | 1,566.90 | 17.46 | 244 | -4.30 | 22.90 | |
1,322.60 | 8,671.76 | 43.41 | 1,290.20 | 17.77 | 194 | 11.00 | 35.99 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
14.76 %
Net Income Growth
60.97 %
Cash Flow Change
11.26 %
ROE
36.18 %
ROCE
2.58 %
EBITDA Margin (Avg.)
12.43 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Fixed Assets | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,988 |
| Current Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,641 | 4,061 | 4,337 | 5,280 | 7,029 |
| Capital Work in Progress | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 |
| Investments | 146 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 2,487 |
| Other Assets | 2,557 | 2,448 | 2,775 | 2,776 | 2,918 | 3,237 | 3,062 | 4,112 | 4,725 | 5,230 | 6,261 |
| Total Liabilities | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Current Liabilities | 1,076 | 1,250 | 963 | 1,567 | 1,956 | 2,337 | 2,038 | 2,434 | 3,325 | 4,665 | 4,579 |
| Non Current Liabilities | 2,159 | 2,701 | 3,718 | 3,662 | 3,759 | 5,531 | 4,577 | 4,932 | 4,572 | 4,768 | 7,426 |
| Total Equity | 3,244 | 3,409 | 3,438 | 3,384 | 3,469 | 3,470 | 4,802 | 5,903 | 6,531 | 7,321 | 8,653 |
| Reserve & Surplus | 3,101 | 3,262 | 3,240 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 |
| Share Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 95 | 45 | 158 | -113 | 72 | 73 |
| Investing Activities | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | -3,381 |
| Operating Activities | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | 2,136 |
| Financing Activities | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | -311 | 1,317 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 29.82 % | 29.82 % | 29.82 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.34 % | 29.34 % | 28.02 % | 28.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 45.63 % | 43.92 % | 45.37 % | 45.27 % | 42.74 % | 43.49 % | 44.20 % | 43.54 % |
| DIIs | 9.16 % | 10.84 % | 12.24 % | 12.13 % | 12.45 % | 14.89 % | 14.59 % | 16.56 % | 17.76 % | 16.31 % | 18.60 % | 17.97 % | 19.55 % | 21.14 % | 19.95 % | 19.98 % | 22.29 % | 21.34 % | 21.12 % | 21.51 % |
| Government | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % |
| Public / Retail | 4.07 % | 3.99 % | 4.24 % | 4.03 % | 4.27 % | 4.48 % | 4.23 % | 4.13 % | 4.04 % | 3.90 % | 4.04 % | 3.70 % | 3.74 % | 3.81 % | 3.62 % | 3.65 % | 3.81 % | 3.98 % | 4.44 % | 4.70 % |
| Others | 56.73 % | 55.13 % | 53.47 % | 54.29 % | 53.73 % | 51.07 % | 51.63 % | 49.75 % | 48.64 % | 50.23 % | 47.80 % | 48.76 % | 1.52 % | 1.57 % | 1.50 % | 1.54 % | 1.60 % | 1.62 % | 1.99 % | 2.01 % |
| No of Share Holders | 67,091 | 75,153 | 98,452 | 99,135 | 1,26,226 | 1,46,320 | 1,35,923 | 1,31,636 | 1,31,937 | 1,20,030 | 1,31,565 | 1,19,578 | 1,30,664 | 1,27,754 | 1,19,245 | 1,27,802 | 1,34,058 | 1,41,007 | 1,60,556 | 1,78,648 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 | 12.66 | 0.00 |
| Dividend Yield (%) | 0.56 | 0.41 | 0.53 | 0.21 | 0.07 | 0.27 | 0.24 | 0.24 | 0.19 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Feb 2026 |  Quarterly Result Announcement | NA | 10 Feb 2026 | 7,272.50 | 6,803.00 |
| 21 Aug 2021 |  Dividend | ₹ 3.00 /share | 18 Aug 2021 | 3,244.80 | 4,746.50 |
| 20 Aug 2022 | Dividend | ₹ 11.75 /share | 18 Aug 2022 | 3,524.30 | 4,135.35 |
| 24 Feb 2023 | Dividend | ₹ 6.00 /share | 24 Feb 2023 | 4,355.10 | 4,448.85 |
| 19 Aug 2023 | Dividend | ₹ 9.00 /share | 18 Aug 2023 | 4,646.10 | 4,848.35 |
| 20 Feb 2024 | Dividend | ₹ 6.00 /share | 20 Feb 2024 | 6,179.35 | 6,656.25 |
| 17 Aug 2024 | Dividend | ₹ 10.00 /share | 16 Aug 2024 | 5,903.45 | 6,686.90 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 6,704.00 | 6,855.95 |
| 06 Nov 2024 | Quarterly Result Announcement | NA | 06 Nov 2024 | 7,092.60 | 6,966.30 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 6,828.10 | 6,790.55 |
| 15 Feb 2025 | Dividend | ₹ 9.00 /share | 14 Feb 2025 | 6,790.55 | 6,266.65 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 6,974.00 | 6,923.00 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 7,352.50 | 7,259.00 |
| 19 Aug 2025 | Dividend | ₹ 10.00 /share | 19 Aug 2025 | 6,923.00 | 7,822.50 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 6,923.00 | 7,726.60 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 7,671.00 | 7,813.25 |
Announcements
Announcement under Regulation 30 (LODR)-Credit Rating
4 hrs ago
4 hrs agoRevised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 201112 hrs ago
12 hrs agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 201112 hrs ago
12 hrs agoDisclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).6 days ago
6 days agoBoard Meeting Intimation for Notice Of The Board MeetingJan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Subject: Receipt Of Observation Letter From The BSE Limited (BSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (Transferor Company 1) Keimed Private Limited (TranDec 24, 2025
Dec 24, 2025Subject: Receipt Of Observation Letter With No Objection From The National Stock Exchange Of India Limited (NSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (TraDec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Intimation Of Receipt Of In - Principle Approval From BSE Limited And National Stock Exchange Of India Limited For Issue And Allotment Of Maximum Of 2156770 Equity Shares Of Rs.5/- Each Under Apollo Hospitals Enterprise Limited - Employee Stock Option PlaNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Nov 06, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2025
Oct 30, 2025Board Meeting Intimation for Notice Of The Board MeetingOct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionOct 04, 2025
Oct 04, 2025Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).Sep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-AcquisitionSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 12, 2025
Sep 12, 2025Board Meeting Outcome for Outcome Of The Board MeetingSep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 30, 2025
Aug 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 29, 2025
Aug 29, 2025Newspaper Advertisement(S) Regarding Notice Of Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 20, 2025
Aug 20, 2025Update On Outcome Of The Board Meeting - 12Th August 2025Aug 14, 2025
Aug 14, 2025Reply To Your Mail Ref No. L/SURV/ONL/PV/AA/ 2025-2026 / 352 Dated 14Th August 2025Aug 14, 2025
Aug 14, 2025Clarification sought from Apollo Hospitals Enterprise LtdAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2025
Aug 12, 2025As Per Annexure EnclosedAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-AcquisitionAug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of The Board MeetingAug 12, 2025
Aug 12, 2025Submission Of Newspaper Advertisements - 44Th Annual General Meeting & IEPF Transfer NoticeAug 08, 2025
Aug 08, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Aug 07, 2025Reg. 34 (1) Annual Report.Aug 06, 2025
Aug 06, 2025Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)
Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2025
Jul 29, 2025Board Meeting Intimation for Notice For The Board MeetingJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 01, 2025
Jul 01, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 32.67
ATR(14)
Less Volatile 147.46
STOCH(9,6)
Neutral 21.77
STOCH RSI(14)
Oversold 0.43
MACD(12,26)
Bearish -48.09
ADX(14)
Strong Trend 29.45
UO(9)
Bearish 50.01
ROC(12)
Downtrend And Accelerating -7.42
WillR(14)
Oversold -86.54
About Apollo Hospitals
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in...more
Chairperson NamePreetha Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
